| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 9,750 | 9,210 | 8,774 | 8,904 | | Cost of Revenue | 1,812 | 1,723 | 1,797 | 1,659 | | | Gross Profit | 7,938 | 7,487 | 6,977 | 7,245 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,972 | 2,169 | 1,937 | 2,002 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,130 | 1,090 | 1,069 | 913 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4,836 | 4,228 | 3,971 | 4,330 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (156) | 118 | (243) | (806) | | Earnings Before Interest And Taxes | 4,680 | 4,346 | 3,728 | 3,524 | | Interest Expense | 1,254 | 1,262 | 1,271 | 374 | | Income Before Tax | 3,426 | 3,084 | 2,457 | 3,150 | | Income Tax Expense | 1,335 | 1,171 | 960 | 1,185 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,091 | 1,913 | 1,497 | 1,965 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,091 | 1,913 | 1,497 | 1,965 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,091 | $1,913 | $1,497 | $1,965 |
|
0.07% Nasdaq 
0.03%
Income Statement
